Text Size
32 studies found for:    Open Studies | "Acromegaly"

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Acromegaly"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown † Lanreotide Levels in Acromegaly
Condition: Acromegaly
Intervention: Other: Blood draw
2 Recruiting The Treatment and Natural History of Acromegaly
Conditions: Acromegaly;   Pituitary Neoplasm
Intervention:
3 Recruiting A Prospective Study of Outcome After Therapy for Acromegaly
Condition: Acromegaly
Intervention:
4 Unknown † Ultrasound Guided Sandostatin LAR Injection in Acromegaly
Condition: Acromegaly
Intervention: Drug: Sandostatin LAR
5 Not yet recruiting Epidemiology of Acromegaly
Condition: Acromegaly
Intervention:
6 Recruiting Efficacy and Safety of Octreolin for Acromegaly
Condition: Acromegaly
Intervention: Drug: Active oral octreotide study drug therapy
7 Recruiting Study of Heart Effects When Growth Hormone (GH) is Used for Growth Hormone Deficiency (GHD) Following Cure of Acromegaly
Condition: Acromegaly
Intervention: Procedure: echocardiogram
8 Not yet recruiting Somatostatin Analogue Treatment of Acromegaly: Molecular Aspects
Conditions: Acromegaly;   Somatostatin;   Metabolism;   Signal Transduction
Intervention: Drug: GH
9 Recruiting Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly
Condition: Acromegaly
Interventions: Drug: Pasireotide (SOM230);   Drug: octreotide LAR 30mg;   Drug: lanreotide ATG 120mg;   Drug: octreotide LAR 30mg or lanreotide ATG 120mg
10 Recruiting Somatuline® Depot (Lanreotide) for Acromegaly Post-Marketing Observational Study
Condition: Acromegaly
Intervention:
11 Recruiting Treatment of Acromegaly With Somatostatin Analogs: GH vs. IGF-I as Primary Biochemical Target
Condition: Acromegaly
Intervention: Drug: Sandostatin® LAR
12 Unknown † Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant
Conditions: Acromegaly;   Heart Failure;   Hypertrophy, Left Ventricular
Intervention: Drug: pegvisomant
13 Unknown † A Study Examining the Peri- and Post-operative Dynamics of the Growth Hormone (GH) - IGF-1 Axis in Subjects With Acromegaly During the First Year After Surgical Resection
Condition: Acromegaly
Intervention: Other: OGTT
14 Recruiting Efficacy and Safety of Pasireotide LAR in Japanese Patients With Acromegaly or Pituitary Gigantism
Condition: Acromegaly, Pituitary Gigantism
Intervention: Drug: SOM230LAR
15 Not yet recruiting Ectopic Lipid Deposition and Insulin Resistance in After Treatment of Acromegaly
Condition: Acromegaly
Intervention: Device: Proton magnetic resonance (MR) spectroscopy
16 Recruiting Prospective Study on Changes in Acromegaly
Condition: Acromegaly
Intervention:
17 Recruiting Somatuline Predictive Factors in Acromegaly and NET
Conditions: Acromegaly;   Neuroendocrine Tumours
Intervention: Drug: Somatuline Autogel® 60, 90 or 120 mg
18 Recruiting Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors
Conditions: Acromegaly;   Nonfunctioning Pituitary Tumor
Intervention:
19 Recruiting Acromegaly Combination Treatment Study
Condition: Acromegaly
Interventions: Drug: Pegvisomant;   Drug: Somatostatin Receptor Ligand (SRL)
20 Unknown † Measurement of Outcome of Surgical Treatment in Patients With Acromegaly
Condition: Acromegaly
Intervention:
To Top

Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results
† Indicates status has not been verified in more than two years